Ipsen (United States)

Ipsen (United States)

Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on transformative medicines in three therapeutic areas: oncology, rare disease and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Ipsen (United States), United States, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

53%


Total
Publications

344


Total Open
Publications

183


Total
Citations

4.1K


Open Access
Percentage

53%


Total
Publications

344


Total Open
Publications

183


Total
Citations

4.1K

Wikipedia

Website

download

Breakdown

24% 27% 2% 47%

Publisher Open

24%

Both

27%

Other Platform Open

2%

Closed

47%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0510152025303540455055Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

25%OA Journal

OA Journal 25%

43

Hybrid 61%

108

No Guarantees 14%

25

Other Platform Open

Domain 87%

88

Institution 17%

17

Public 15%

15

Other Internet 10%

10

Preprint 1%

1

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
88
Europe PMC
Domain
38
Semantic Scholar
Public
10
Figshare
Public
4
California Digital Library - eScholarship
Other Internet
3
University of Oxford - Oxford Academic Notes & Queries
Institution
2
University of Edinburgh - Edinburgh Research Explorer
Institution
2
University of Birmingham - University of Birmingham Research Portal
Institution
2
University College London - UCL Discovery
Institution
2
Red Federada de Repositorios Institucionales de Publicaciones Científicas - LA Referencia
Other Internet
2
1 / 4

Data updated 13 May 2024

Share

Share

Share